Novocure to Participate in Upcoming Investor Conferences

NovocureNov 27 00:00 ET

Novocure Secures FDA Approval for Add-ons to Brain Cancer Treatment Wearable

Yahoo FinanceNov 21 11:58 ET

NovoCure's Buy Rating Backed by FDA Approval and Strategic Growth Plans Amidst Potential Risks

TipRanksNov 21 10:25 ET · Ratings

The FDA Approves Novocure's New Head Flexible Electrode Transducer Arrays For Use With Optune Gio For Adult Patients With Glioblastoma Multiforme, Novocure Plans To Convert Optune Gio Users In The U.S. To The New HFE Arrays Through The First Half Of...

BenzingaNov 21 07:05 ET

Express News | Novocure Ltd - to Convert Optune Gio Users to New Hfe Arrays by Mid-2025

ReutersNov 21 07:00 ET

Express News | FDA Approves Novocure’s Innovative Hfe Transducer Arrays for Use With Optune Gio® for Glioblastoma

ReutersNov 21 07:00 ET